Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Case Report: Lupus Nephritis or a Mimic?

Matthew J. Mandell, DO, Yishui Chen, MD, Prerna Rastogi, MD, PhD, & Rebecca Tuetken, MD, PhD  |  Issue: November 2022  |  November 10, 2022

Initial urinalysis several weeks prior to admission showed 2–3+ protein, 2+ blood, and no casts. Proteinuria was quantified with random urine-to-protein-creatinine ratio, which was elevated at 5.65 g/g Cr. The ANA titer was 1:640 in nuclear coarse speckled pattern; tests for anti-Smith and double-stranded DNA antibodies were negative. 

Serum complements were not low. A test for phospholipase A2 receptor (PLA2R) antibody was negative. Tests for human immunodeficiency virus (HIV) antigen and antibody, hepatitis B surface antigen and antibody, and hepatitis C antibody were negative. A test for RPR was positive (1:256), with a positive confirmatory syphilis total antibody test. Chlamydia and gonorrhea polymerase chain reaction testing returned negative. Tests for anti-phospholipid antibodies were negative. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The complete blood count test with differential was normal. Ferritin (408 ng/mL; RR: 12–300 ng/mL for men) and erythrocyte sedimen­tation rate (ESR) (56 mm/Hr; RR: 0–15 mm/Hr) were elevated; C-reactive protein (CRP) was just above the upper limit of normal (0.6 mg/dL; RR: <0.5 mg/dL). 

Liver function tests revealed hypo­albuminemia (1.9 g/dL) and elevated alkaline phosphatase (413 U/L; RR: <129 U/L) and gamma-glutamyl transferase (872 U/L; RR: <61 U/L). Serum parvo­virus B19 IgG (1.16 IV; RR: <0.90 IV) and IgM (1.97 IV; RR: <0.90 IV) were consistent with recently acquired infection. 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

A renal biopsy was suggestive of classes II and V lupus nephritis; however, no crescents were identified (see Figure 1, opposite). Renal biopsy showed a combined (segmental) membranous and minimal mesangial pattern of glomerulonephritis with negative PLA2R antibody stain (see Figure 2, opposite). On immunofluorescence, glomeruli showed segmental, capillary loop and full-house pattern (positive for IgG, IgM, IgA, C3, C1q) co-staining (see Figures 3 and 4, this page). Spirochete stain was negative on immunohistochemistry. 

Given the presence of persistent headache, along with neck tenderness and positive syphilis testing, a lumbar puncture with cerebrospinal fluid analysis was performed, which revealed normal cell count, negative gram stain, normal glucose and negative venereal disease research laboratory test.

Patient presented with nephrotic syndrome (i.e., nephrotic range: proteinuria, elevated cholesterol and edema), which improved during his hospitalization. He was treated with 30 mg of lisinopril daily and 40 mg of atorvastatin daily. 

FIGURE 3: IMMUNOFLUORESCENCE IgG STAIN

IgG stain is positive in a granular pattern along capillary loop and rare mesangial areas.

(Click to enlarge.)

At his one-month outpatient follow-

up, his edema, headache, arthralgias, malaise, rash and diarrhea had all resolved. His cholesterol had normalized with statin therapy. Repeat urinalysis showed no blood and no protein, and the random urine-to-protein-creatine ratio had completely normalized (0.08 g/g Cr). His serum creatine declined to 1.2 mg/dL. His inflammatory markers had also com­pletely normalized (ESR 1 and CRP <0.5 mg/dL), as had his alkaline phosphatase and albumin.

Discussion

Searching PubMed, we identified only one case of co-infection with syphilis and parvovirus B19 mimicking lupus nephro­pathy, as in our patient.1 Parvovirus B19 and especially syphilis have been reported to cause the same histologic features of lupus nephritis—or so-called pseudo-lupus nephritis. Although the presence of C1q deposits is nearly pathognomonic for lupus nephritis, it can also be seen when parvovirus B19 causes kidney disease.1 

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:case reportFellowsFellows ForumFellows-in-TrainingLupus nephritisparvovirus B19syphilis

Related Articles

    A Case of Lupus Podocytopathy

    June 17, 2024

    Kidney involvement is a major cause of morbidity and mortality in systemic lupus erythematosus (SLE). Collectively termed lupus nephritis, SLE with kidney involvement comes in many subtypes. The current classification by the International Society of Nephrology/Renal Pathology Society (ISN/RPS), however, does not include lupus podocytopathy, which, through various clinical and epidemiologic studies, has recently been…

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

    Tacrolimus Use for Lupus Nephritis Raises Debate over Role in North American Population

    October 10, 2016

    The following summary regarding use of tacrolimus (TAC) in lupus nephritis highlights a number of debatable points. Although the role of TAC in lupus nephritis remains unproved for North American populations, it might be an excellent option in some clinical situations. These situations include lupus flare during pregnancy and also for lupus nephritis when the…

    Immunosuppressive Treatment for Lupus in the Next Decade

    April 13, 2011

    It’s time for a new strategy

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences